GO:0044822 | poly(A) RNA binding | 2.65e-05 | 2.58e-01 | 2.718 | 7 | 25 | 799 |
GO:0005838 | proteasome regulatory particle | 7.32e-05 | 7.15e-01 | 7.231 | 2 | 2 | 10 |
GO:0022624 | proteasome accessory complex | 1.48e-04 | 1.00e+00 | 6.746 | 2 | 2 | 14 |
GO:0008135 | translation factor activity, nucleic acid binding | 1.70e-04 | 1.00e+00 | 6.646 | 2 | 4 | 15 |
GO:0042981 | regulation of apoptotic process | 3.86e-04 | 1.00e+00 | 4.331 | 3 | 4 | 112 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.30e-03 | 1.00e+00 | 5.195 | 2 | 3 | 41 |
GO:0071987 | WD40-repeat domain binding | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:1990264 | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0006412 | translation | 1.49e-03 | 1.00e+00 | 3.662 | 3 | 13 | 178 |
GO:0000502 | proteasome complex | 1.71e-03 | 1.00e+00 | 4.998 | 2 | 2 | 47 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.09e-03 | 1.00e+00 | 4.853 | 2 | 3 | 52 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.17e-03 | 1.00e+00 | 4.825 | 2 | 3 | 53 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.42e-03 | 1.00e+00 | 4.746 | 2 | 3 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.51e-03 | 1.00e+00 | 4.720 | 2 | 3 | 57 |
GO:0001672 | regulation of chromatin assembly or disassembly | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0090231 | regulation of spindle checkpoint | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.77e-03 | 1.00e+00 | 4.646 | 2 | 3 | 60 |
GO:0016020 | membrane | 2.79e-03 | 1.00e+00 | 1.901 | 6 | 25 | 1207 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 2.86e-03 | 1.00e+00 | 4.622 | 2 | 3 | 61 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.25e-03 | 1.00e+00 | 4.531 | 2 | 3 | 65 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 3.75e-03 | 1.00e+00 | 4.424 | 2 | 4 | 70 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0007143 | female meiotic division | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0097443 | sorting endosome | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0010467 | gene expression | 4.28e-03 | 1.00e+00 | 2.490 | 4 | 17 | 535 |
GO:0050658 | RNA transport | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0030157 | pancreatic juice secretion | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0000209 | protein polyubiquitination | 6.40e-03 | 1.00e+00 | 4.029 | 2 | 3 | 92 |
GO:0000974 | Prp19 complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0000278 | mitotic cell cycle | 7.41e-03 | 1.00e+00 | 2.843 | 3 | 9 | 314 |
GO:0060136 | embryonic process involved in female pregnancy | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0034641 | cellular nitrogen compound metabolic process | 8.27e-03 | 1.00e+00 | 3.839 | 2 | 3 | 105 |
GO:0030126 | COPI vesicle coat | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 7 |
GO:0005662 | DNA replication factor A complex | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.16e-02 | 1.00e+00 | 3.587 | 2 | 6 | 125 |
GO:0030100 | regulation of endocytosis | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 9 |
GO:0000398 | mRNA splicing, via spliceosome | 1.21e-02 | 1.00e+00 | 3.553 | 2 | 2 | 128 |
GO:0071480 | cellular response to gamma radiation | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0007051 | spindle organization | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0010507 | negative regulation of autophagy | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0043488 | regulation of mRNA stability | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0009966 | regulation of signal transduction | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 1 | 11 |
GO:0030234 | enzyme regulator activity | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 1 | 11 |
GO:0051297 | centrosome organization | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 12 |
GO:0015935 | small ribosomal subunit | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 4 | 12 |
GO:0035371 | microtubule plus-end | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0001701 | in utero embryonic development | 1.72e-02 | 1.00e+00 | 3.286 | 2 | 2 | 154 |
GO:0042176 | regulation of protein catabolic process | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0060334 | regulation of interferon-gamma-mediated signaling pathway | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 15 |
GO:0005829 | cytosol | 1.98e-02 | 1.00e+00 | 1.335 | 6 | 33 | 1787 |
GO:0016071 | mRNA metabolic process | 2.07e-02 | 1.00e+00 | 3.144 | 2 | 11 | 170 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 1 | 16 |
GO:0005689 | U12-type spliceosomal complex | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 2 | 17 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 1 | 17 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 1 | 19 |
GO:0016070 | RNA metabolic process | 2.50e-02 | 1.00e+00 | 2.998 | 2 | 11 | 188 |
GO:0001892 | embryonic placenta development | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 1 | 20 |
GO:0032720 | negative regulation of tumor necrosis factor production | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 1 | 20 |
GO:0005761 | mitochondrial ribosome | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 1 | 20 |
GO:0046875 | ephrin receptor binding | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 1 | 20 |
GO:0051781 | positive regulation of cell division | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 1 | 22 |
GO:0040018 | positive regulation of multicellular organism growth | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 1 | 22 |
GO:0034605 | cellular response to heat | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 1 | 22 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 1 | 23 |
GO:0043234 | protein complex | 3.07e-02 | 1.00e+00 | 2.839 | 2 | 8 | 210 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 1 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 1 | 25 |
GO:0005158 | insulin receptor binding | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 1 | 25 |
GO:0030971 | receptor tyrosine kinase binding | 3.41e-02 | 1.00e+00 | 4.853 | 1 | 1 | 26 |
GO:0010494 | cytoplasmic stress granule | 3.41e-02 | 1.00e+00 | 4.853 | 1 | 2 | 26 |
GO:0005737 | cytoplasm | 3.61e-02 | 1.00e+00 | 0.998 | 7 | 39 | 2633 |
GO:0031532 | actin cytoskeleton reorganization | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 2 | 31 |
GO:0003723 | RNA binding | 4.14e-02 | 1.00e+00 | 2.605 | 2 | 6 | 247 |
GO:0003682 | chromatin binding | 4.29e-02 | 1.00e+00 | 2.576 | 2 | 3 | 252 |
GO:0005515 | protein binding | 4.61e-02 | 1.00e+00 | 0.713 | 9 | 50 | 4124 |
GO:0003743 | translation initiation factor activity | 4.82e-02 | 1.00e+00 | 4.344 | 1 | 5 | 37 |
GO:0006952 | defense response | 4.82e-02 | 1.00e+00 | 4.344 | 1 | 1 | 37 |
GO:0006417 | regulation of translation | 5.07e-02 | 1.00e+00 | 4.268 | 1 | 3 | 39 |
GO:0005840 | ribosome | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 3 | 40 |
GO:0005882 | intermediate filament | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 2 | 40 |
GO:0070062 | extracellular vesicular exosome | 5.26e-02 | 1.00e+00 | 1.195 | 5 | 28 | 1641 |
GO:0060337 | type I interferon signaling pathway | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 1 | 45 |
GO:0006468 | protein phosphorylation | 5.90e-02 | 1.00e+00 | 2.319 | 2 | 3 | 301 |
GO:0004725 | protein tyrosine phosphatase activity | 6.33e-02 | 1.00e+00 | 3.938 | 1 | 1 | 49 |
GO:0007059 | chromosome segregation | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 1 | 50 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 1 | 50 |
GO:0018105 | peptidyl-serine phosphorylation | 6.58e-02 | 1.00e+00 | 3.881 | 1 | 2 | 51 |
GO:0043066 | negative regulation of apoptotic process | 6.65e-02 | 1.00e+00 | 2.222 | 2 | 6 | 322 |
GO:0005730 | nucleolus | 6.82e-02 | 1.00e+00 | 1.304 | 4 | 21 | 1217 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 6.96e-02 | 1.00e+00 | 3.798 | 1 | 1 | 54 |
GO:0008584 | male gonad development | 7.33e-02 | 1.00e+00 | 3.720 | 1 | 1 | 57 |
GO:0003697 | single-stranded DNA binding | 7.33e-02 | 1.00e+00 | 3.720 | 1 | 3 | 57 |
GO:0048471 | perinuclear region of cytoplasm | 7.47e-02 | 1.00e+00 | 2.127 | 2 | 7 | 344 |
GO:0005179 | hormone activity | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 1 | 60 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 2 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 7.83e-02 | 1.00e+00 | 3.622 | 1 | 1 | 61 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 7.83e-02 | 1.00e+00 | 3.622 | 1 | 1 | 61 |
GO:0000922 | spindle pole | 8.69e-02 | 1.00e+00 | 3.466 | 1 | 3 | 68 |
GO:0016568 | chromatin modification | 8.69e-02 | 1.00e+00 | 3.466 | 1 | 2 | 68 |
GO:0031410 | cytoplasmic vesicle | 9.42e-02 | 1.00e+00 | 3.344 | 1 | 1 | 74 |
GO:0015630 | microtubule cytoskeleton | 9.54e-02 | 1.00e+00 | 3.324 | 1 | 2 | 75 |
GO:0006915 | apoptotic process | 1.02e-01 | 1.00e+00 | 1.870 | 2 | 4 | 411 |
GO:0005634 | nucleus | 1.02e-01 | 1.00e+00 | 0.696 | 7 | 40 | 3246 |
GO:0005654 | nucleoplasm | 1.04e-01 | 1.00e+00 | 1.363 | 3 | 16 | 876 |
GO:0030529 | ribonucleoprotein complex | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 3 | 82 |
GO:0003690 | double-stranded DNA binding | 1.05e-01 | 1.00e+00 | 3.178 | 1 | 1 | 83 |
GO:0016032 | viral process | 1.09e-01 | 1.00e+00 | 1.811 | 2 | 13 | 428 |
GO:0061024 | membrane organization | 1.12e-01 | 1.00e+00 | 3.077 | 1 | 3 | 89 |
GO:0006886 | intracellular protein transport | 1.12e-01 | 1.00e+00 | 3.077 | 1 | 1 | 89 |
GO:0032496 | response to lipopolysaccharide | 1.17e-01 | 1.00e+00 | 3.014 | 1 | 1 | 93 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.21e-01 | 1.00e+00 | 1.720 | 2 | 6 | 456 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 3 | 97 |
GO:0008286 | insulin receptor signaling pathway | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 2 | 97 |
GO:0006413 | translational initiation | 1.24e-01 | 1.00e+00 | 2.924 | 1 | 12 | 99 |
GO:0005198 | structural molecule activity | 1.26e-01 | 1.00e+00 | 2.895 | 1 | 1 | 101 |
GO:0003735 | structural constituent of ribosome | 1.36e-01 | 1.00e+00 | 2.785 | 1 | 8 | 109 |
GO:0005769 | early endosome | 1.36e-01 | 1.00e+00 | 2.785 | 1 | 1 | 109 |
GO:0007049 | cell cycle | 1.43e-01 | 1.00e+00 | 2.707 | 1 | 2 | 115 |
GO:0006974 | cellular response to DNA damage stimulus | 1.50e-01 | 1.00e+00 | 2.634 | 1 | 2 | 121 |
GO:0016607 | nuclear speck | 1.51e-01 | 1.00e+00 | 2.622 | 1 | 2 | 122 |
GO:0031965 | nuclear membrane | 1.60e-01 | 1.00e+00 | 2.531 | 1 | 2 | 130 |
GO:0030168 | platelet activation | 1.72e-01 | 1.00e+00 | 2.413 | 1 | 3 | 141 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.73e-01 | 1.00e+00 | 2.403 | 1 | 4 | 142 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.79e-01 | 1.00e+00 | 1.368 | 2 | 9 | 582 |
GO:0008380 | RNA splicing | 1.99e-01 | 1.00e+00 | 2.187 | 1 | 4 | 165 |
GO:0007067 | mitotic nuclear division | 1.99e-01 | 1.00e+00 | 2.187 | 1 | 5 | 165 |
GO:0007283 | spermatogenesis | 2.02e-01 | 1.00e+00 | 2.161 | 1 | 2 | 168 |
GO:0019221 | cytokine-mediated signaling pathway | 2.06e-01 | 1.00e+00 | 2.127 | 1 | 4 | 172 |
GO:0004674 | protein serine/threonine kinase activity | 2.33e-01 | 1.00e+00 | 1.931 | 1 | 3 | 197 |
GO:0035556 | intracellular signal transduction | 2.35e-01 | 1.00e+00 | 1.916 | 1 | 3 | 199 |
GO:0006355 | regulation of transcription, DNA-templated | 2.46e-01 | 1.00e+00 | 1.071 | 2 | 9 | 715 |
GO:0019899 | enzyme binding | 2.46e-01 | 1.00e+00 | 1.839 | 1 | 3 | 210 |
GO:0005813 | centrosome | 2.53e-01 | 1.00e+00 | 1.791 | 1 | 6 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 2.54e-01 | 1.00e+00 | 1.785 | 1 | 1 | 218 |
GO:0019901 | protein kinase binding | 2.69e-01 | 1.00e+00 | 1.695 | 1 | 8 | 232 |
GO:0044281 | small molecule metabolic process | 3.11e-01 | 1.00e+00 | 0.832 | 2 | 8 | 844 |
GO:0008285 | negative regulation of cell proliferation | 3.12e-01 | 1.00e+00 | 1.439 | 1 | 3 | 277 |
GO:0003677 | DNA binding | 3.64e-01 | 1.00e+00 | 0.666 | 2 | 12 | 947 |
GO:0007596 | blood coagulation | 3.68e-01 | 1.00e+00 | 1.148 | 1 | 4 | 339 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.70e-01 | 1.00e+00 | 1.139 | 1 | 2 | 341 |
GO:0044267 | cellular protein metabolic process | 3.80e-01 | 1.00e+00 | 1.094 | 1 | 13 | 352 |
GO:0005783 | endoplasmic reticulum | 4.04e-01 | 1.00e+00 | 0.979 | 1 | 3 | 381 |
GO:0005789 | endoplasmic reticulum membrane | 4.09e-01 | 1.00e+00 | 0.957 | 1 | 3 | 387 |
GO:0006351 | transcription, DNA-templated | 4.28e-01 | 1.00e+00 | 0.482 | 2 | 15 | 1076 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.88e-01 | 1.00e+00 | 0.222 | 1 | 8 | 644 |
GO:0005615 | extracellular space | 5.92e-01 | 1.00e+00 | 0.206 | 1 | 2 | 651 |
GO:0008270 | zinc ion binding | 6.34e-01 | 1.00e+00 | 0.047 | 1 | 5 | 727 |
GO:0005524 | ATP binding | 7.12e-01 | 1.00e+00 | -0.248 | 1 | 10 | 892 |
GO:0005886 | plasma membrane | 7.17e-01 | 1.00e+00 | -0.248 | 2 | 13 | 1784 |
GO:0046872 | metal ion binding | 7.30e-01 | 1.00e+00 | -0.314 | 1 | 10 | 934 |